John M. Storring
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Improvement in quality of life in MDS patients who become transfusion independent after treatment.
Journal: Leukemia & lymphoma
Published: November 09, 2024
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.
Journal: Annals of hematology
Published: September 03, 2024
Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada.
Journal: Acta haematologica
Published: February 20, 2023
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Journal: Leukemia & lymphoma
Published: January 06, 2023
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.
Journal: British journal of haematology
Published: January 25, 2021
Revised 15-item MDS-specific frailty scale maintains prognostic potential.
Journal: Leukemia
Published: April 30, 2020
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring.
Journal: Leukemia
Published: July 31, 2019
GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
Journal: Journal of pediatric hematology/oncology
Published: April 06, 2018
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Journal: American journal of hematology
Published: June 19, 2017
Last Updated: 09/26/2026